Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseGraves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hyperthyroidism, immune system disorder, thyroid gland disorderRecruitingPhase 22026-08-25NCT07018323

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunovant Sciences GmbH8

163 results · Page 1 of 7

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site Nnumber - 3003WroclawPoland1
Site Number - 1000MiamiUnited States1
Site Number - 1001Morehead CityUnited States1
Site Number - 1002El PasoUnited States1
Site Number - 1003Fort WorthUnited States1
Site Number - 1004Kansas CityUnited States1
Site Number - 1007Oklahoma CityUnited States1
Site Number - 1008HialeahUnited States1
Site Number - 1009New YorkUnited States1
Site Number - 1010Chapel HillUnited States1
Site Number - 1011San AntonioUnited States1
Site Number - 1012RenoUnited States1
Site Number - 1013AuroraUnited States1
Site Number - 1015TucsonUnited States1
Site Number - 1016NorfolkUnited States1
Site Number - 1017MemphisUnited States1
Site Number - 1018WilliamsvilleUnited States1
Site Number - 1019St LouisUnited States1
Site Number - 1020ColumbusUnited States1
Site Number - 1021IrvingUnited States1
Site Number - 1022TopekaUnited States1
Site Number - 1024DoralUnited States1
Site Number - 1025McKinneyUnited States1
Site Number - 1026HickoryUnited States1
Site Number - 1027New Hyde ParkUnited States1